コンテンツへスキップ
Merck
  • Ligand-free Pd-catalyzed C-N cross-coupling/cyclization strategy: an unprecedented access to 1-thienyl pyrroloquinoxalines for the new approach towards apoptosis.

Ligand-free Pd-catalyzed C-N cross-coupling/cyclization strategy: an unprecedented access to 1-thienyl pyrroloquinoxalines for the new approach towards apoptosis.

European journal of medicinal chemistry (2014-08-30)
Sunder Kumar Kolli, Ali Nakhi, Sivakumar Archana, Maneesha Saridena, Girdhar Singh Deora, Swapna Yellanki, Raghavender Medisetti, Pushkar Kulkarni, R Ramesh Raju, Manojit Pal
要旨

The link between PDE4 and apoptosis prompted us to design and synthesize for the first time a series of novel 1-thienyl pyrroloquinoxalines as potential PDE4 inhibitors/apoptotic agents. A ligand-free Pd-catalyzed C-N cross-coupling/cyclization strategy has been developed for the rapid and milder access to this class of compounds some of which showed interesting pharmacological properties when tested in vitro and in zebrafish embryos.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(−)-アデノシン3′5′-サイクリック一リン酸, ≥98.5% (HPLC), powder
Sigma-Aldrich
アデノシン 3′,5′-環状一リン酸 トリス塩, ≥97% (HPLC), powder